Tandem Diabetes Care Inc : Leerink Partners Cuts Target Price to $59 From $62
Tandem Diabetes Care Inc: Leerink Partners將目標價從$62降至$59
Tandem Diabetes Care Inc : Leerink Partners Cuts Target Price to $59 From $62
Tandem Diabetes Care Inc: Leerink Partners將目標價從$62降至$59
譯文內容由第三人軟體翻譯。